Biofeedback for Hemianopia Vision Rehabilitation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorUniversity Health Network, Toronto

About this trial

Patients with brain injury secondary to stroke, surgery, or trauma frequently suffer from homonymous hemianopia, defined as vision loss in one hemifield secondary to retro- chiasmal lesion. Classic and effective saccadic compensatory training therapies are current aim to reorganize the control of visual information processing and eye movements or, in other words, to induce or improve oculomotor adaptation to visual field loss. Patients learn to intentionally shift their eyes and, thus, their visual field border, into the area corresponding to their blind visual field. This shift brings the visual information from the blind hemifield into the seeing hemifield for further processing. Patients learn, therefore, to efficiently use their eyes "to keep the 'blind side' in sight". Biofeedback training (BT) is the latest and newest technique for oculomotor control training in cases with low vision when using available modules in the new microperimetry instruments. Studies in the literature highlighted positive benefits from using BT in a variety of central vision loss, nystagmus cases, and others.The purpose of this study is to assess systematically the impact of BT in a series of cases with hemianopia and formulate guidelines for further use of this intervention in vision rehabilitation of hemianopia cases in general.

Eligibility criteria

Qualifiers

hemianopia cases previously diagnosed accordingly by microperimetry and other tests as needed

18-90 years old

ability to follow the visual and auditory stimuli and training instructions

Disqualifiers

previous or current treatment for low vision rehabilitation

ocular diseases

other serious clinical conditions not related to the hemianopia physiopathology

both eyes with media opacity that impairs microperimetry testing

Trial design

Treatments tested in this trial

  • Biofeedback training

Treatment groups

32 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University Health Network, Toronto

Lead sponsor

University of Toronto

Collaborator